Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Boehringer Ingelheim

FunderResearch funding and supported work

Boehringer Ingelheim is a funder indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,779 works.

4,779
Works

What are the most-cited papers on Boehringer Ingelheim?

ScholarIQmost cited works
Empagliflozin after Acute Myocardial Infarction
Javed Butler, W. Schuyler Jones, Jacob A. Udell, Stefan D. Anker, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Isabella Zwiener, Offer Amir, M. Cecilia Bahit, Johann Bauersachs, Antoni Bayés‐Genís, Yundai Chen, Vijay Chopra, Gemma A. Figtree, Junbo Ge, Shaun G. Goodman, Nina Gotcheva, Shinya Goto, Tomasz Gąsior, Waheed Jamal, James L. Januzzi, Myung Ho Jeong, Yu. M. Lopatin, Renato D. Lópes, Béla Merkely, Puja B. Parikh, Alexander Parkhomenko, Piotr Ponikowski, Xavier Rosselló, Morten Schou, Dragan Šimić, Philippe Gabríel Steg, Joanna Szachniewicz, Peter van der Meer, Dragoş Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez
New England Journal of Medicine. 2024281 CitationsOPEN ACCESS
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
Li Shen, Søren Lund Kristensen, Olof Bengtsson, Michael Böhm, Rudolf A. de Boer, Kieran F. Docherty, Silvio E. Inzucchi, Tzvetana Katova, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Daniel Lindholm, M. Felipe A. Martinez, Eileen O’Meara, José Carlos Nicolau, Mark C. Petrie, Piotr Ponikowski, Marc S. Sabatine, Morten Schou, Mikaela Sjöstrand, Scott D. Solomon, Pardeep S. Jhund, John J.V. McMurray
JACC Heart Failure. 2021127 CitationsOPEN ACCESS
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
Iris E. Beldhuis, Peder L. Myhre, Brian Claggett, Kevin Damman, James C. Fang, Eldrin F. Lewis, Eileen O’Meara, Bertram Pitt, Sanjiv J. Shah, Adriaan A. Voors, Marc A. Pfeffer, Scott D. Solomon, Akshay S. Desai
JACC Heart Failure. 201899 CitationsOPEN ACCESS
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories
Adeera Levin, Vlado Perkovic, David C. Wheeler, Stefan Hantel, Jyothis T. George, Maximilian von Eynatten, Audrey Koitka‐Weber, Christoph Wanner, on behalf of the EMPA-REG OUTCOME Investigators
Clinical Journal of the American Society of Nephrology. 202084 CitationsOPEN ACCESS
Secondary analysis of the EMPACT-MI trial reveals cardiovascular–kidney efficacy and safety of empagliflozin after acute myocardial infarction
Rahul Aggarwal, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker, Josephine Harrington, W. Schuyler Jones, Michaela Mattheus, Mark C. Petrie, Dominik Steubl, Mikhail Sumin, Vikram Thanam, Jacob A. Udell, Javed Butler
Nature Cardiovascular Research. 20253 CitationsOPEN ACCESS
470M+ articles · free account